how to get tirzepatide from eli lilly weight-loss drug appears suppress binge-eating signal, small study finds Lilly releases Zepbound® (tirzepatide) single-dose

Reprod Biol Endocrinol (2019) 17:17

For patients with obesity-related conditions, NICE guideline NG246 (Obesity: identification, assessment and management, 2023) and NICE guideline NG28 (Type 2 diabetes in adults: management) recommend regular monitoring of metabolic parameters including lipid profiles, blood glucose, blood pressure, and renal function

Moreover, Eli Lilly and Company adopts various initiatives for patient access

Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. Where some medtech leaders might see GLP-1 drugs as a big threat to their territory, Farrell sees it as an opportunity to funnel more people toward CPAP treatment by boosting awareness of chronic diseases like sleep apnea, and driving more people who suffer from these diseases into treatment pathways they may not have been previously open to or aware of, such as CPAP machines

Given the wide use of GLP-1RA, clinicians should be well informed about important potential adverse events

This overlap prevents the hunger rebound that occurs during extended off-treatment periods